You are here

  • Home
  • Archive
  • Volume 71, Issue 2
  • Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN

Citation Tools

Article menu
Inflammatory bowel disease
Original research
Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gorelik Y, Freilich S, Gerassy-Vainberg S On behalf of the IIRN, et al
Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN
Gut 2022;71:287-295.